Nanoviricides annual stock-based compensation
2009
2016
2018
2019
2020
2021
2022
2023
2024
2025
Nanoviricides Stock-Based Compensation Growth & History (NNVC)
Nanoviricides's stock-based compensation was $223,347 for fiscal 2025.
View full Nanoviricides company overviewNanoviricides annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $223,347 | $222,784 | +39570.87% |
| 2024 | 2024-06-30 | $563 | −$43,437 | −98.72% |
| 2023 | 2023-06-30 | $44,000 | −$294,418 | −87.00% |
| 2022 | 2022-06-30 | $338,418 | $338,418 | — |
| 2021 | 2021-06-30 | $0 | $0 | — |
| 2020 | 2020-06-30 | $0 | −$35,761 | — |
| 2019 | 2019-06-30 | $35,761 | −$120,429 | −77.10% |
| 2018 | 2018-06-30 | $156,190 | — | — |
| 2016 | 2016-06-30 | $158,000 | — | — |
| 2009 | 2009-06-30 | $7,044 | — | — |
Nanoviricides quarterly stock-based compensation
Q1.18
Q2.18
Q1.19
Q2.19
Q3.19
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $71,127 | $12,376 | +21.07% |
| Q2 2026 | 2025-12-31 | $196,684 | — | — |
| Q1 2026 | 2025-09-30 | $49,882 | — | — |
| Q4 2025 | 2025-06-30 | $52,183 | — | — |
| Q3 2025 | 2025-03-31 | $58,751 | — | — |
| Q3 2019 | 2019-03-31 | $35,761 | — | — |
| Q2 2019 | 2018-12-31 | $0 | $0 | — |
| Q1 2019 | 2018-09-30 | $11,920 | $11,920 | — |
| Q2 2018 | 2017-12-31 | $0 | — | — |
| Q1 2018 | 2017-09-30 | $0 | — | — |
Nanoviricides stock-based compensation trends
Over the last five fiscal years, Nanoviricides's stock-based compensation increased from $0 to $223,347, a change of $223,347. The latest reported quarter, Q3 2026, shows $71,127.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanoviricides source filings ↗